Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Chefs' Warehouse
CHEF
$4.51B
| $6.41M | 0.01% |
192,449
+154,149
| +402% | +$5.37M |
|
1352
Modine Manufacturing
MOD
$11.1B
| $6.39M | 0.01% |
321,999
-15,810
| -5% | -$294K |
|
1353
JELD-WEN Holding
JELD
$165M
| $6.39M | 0.01% |
662,400
-337,500
| -34% | -$3.27M |
|
1354
Thomson Reuters
TRI
$44.9B
| $6.39M | 0.01% |
53,154
+42,803
| +414% | +$4.93M |
|
1355
First Business Financial Services
FBIZ
$599M
| $6.39M | 0.01% |
174,765
+5,848
| +3% | +$215K |
|
1356
Community Trust Bancorp
CTBI
$1.44B
| $6.38M | 0.01% |
138,982
-4,900
| -3% | -$223K |
|
1357
SiteOne Landscape Supply
SITE
$4.3B
| $6.38M | 0.01% |
54,400
-94,300
| -63% | -$11M |
|
1358
Frontier Group Holdings
ULCC
$1.54B
| $6.38M | 0.01% |
621,400
+69,700
| +13% | +$811K |
|
|
VVNT
1359
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $6.37M | 0.01% |
535,100
+292,500
| +121% | +$2.63M |
|
|
FFIC
1360
DELISTED
Flushing Financial
FFIC
| $6.36M | 0.01% |
328,100
-10,700
| -3% | -$215K |
|
1361
Valaris
VAL
$5.99B
| $6.34M | 0.01% |
+93,800
| New | +$5.85M |
|
1362
inTEST
INTT
$177M
| $6.34M | 0.01% |
615,537
-61,279
| -9% | -$570K |
|
1363
Build-A-Bear
BBW
$479M
| $6.34M | 0.01% |
265,779
-13,500
| -5% | -$260K |
|
1364
AngioDynamics
ANGO
$646M
| $6.33M | 0.01% |
459,814
+6,800
| +2% | +$94.6K |
|
1365
Alignment Healthcare
ALHC
$2.92B
| $6.32M | 0.01% |
537,500
+78,600
| +17% | +$956K |
|
1366
IPG Photonics
IPGP
$3.65B
| $6.31M | 0.01% |
66,700
-13,300
| -17% | -$1.19M |
|
|
CCRD
1367
DELISTED
CoreCard
CCRD
| $6.31M | 0.01% |
217,697
-26,698
| -11% | -$700K |
|
|
DOC
1368
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $6.31M | 0.01% |
435,800
+105,700
| +32% | +$1.54M |
|
1369
Allegro MicroSystems
ALGM
$8.17B
| $6.3M | 0.01% |
209,800
-173,532
| -45% | -$4.73M |
|
|
SGFY
1370
DELISTED
Signify Health, Inc.
SGFY
| $6.28M | 0.01% |
219,200
-55,000
| -20% | -$1.59M |
|
|
DRD
1371
DRDGold
DRD
$2.09B
| $6.28M | 0.01% |
847,913
-101,601
| -11% | -$625K |
|
1372
Regional Management Corp
RM
$307M
| $6.27M | 0.01% |
223,137
-17,000
| -7% | -$501K |
|
1373
IES Holdings
IESC
$15.1B
| $6.26M | 0.01% |
176,132
-13,700
| -7% | -$444K |
|
1374
TPG
TPG
$8.51B
| $6.26M | 0.01% |
225,000
+214,500
| +2,043% | +$6.75M |
|
1375
Brink's
BCO
$4.7B
| $6.25M | 0.01% |
116,300
+36,600
| +46% | +$2.12M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.